Source: Virtual Congress 2020 – Molecular alterations and immunology in lung cancer
Disease area: -



Rating:

Share or cite this content

Citations should be made in the following way:
W. Luo (Chengdu, China), W. Li (Chengdu, China). Germline mutations in young never-smokers with lung adenocarcinoma. 1645

Member's Comments

No comment yet.

Related content which might interest you: Croatian Caucasians with lung adenocarcinoma harbouring EGFR mutations with and without brain metastasis Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017 Germ-line exon 21 EGFR mutations, V843I and P848L, in nonsmall cell lung cancer patients Source: Eur Respir Rev 2014; 23: 390-392 Year: 2014 p53 gene mutations in lung cancer in Korean Source: Eur Respir J 2005; 26: Suppl. 49, 327s Year: 2005 K-RAS oncogenic mutations in patients with nonsmall cell lung cancer Source: Annual Congress 2007 - Biology of thoracic malignancies Year: 2007 Concordance of p53 and K-ras mutations in induced sputum and corresponding biopsies of patients with nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 18s Year: 2001 Residential radon, EGFR mutations and ALK alterations in never-smoking lung cancer cases Source: Eur Respir J 2016; 48: 1462-1470 Year: 2016 Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort Source: Eur Respir J 2012; 40: 177-184 Year: 2012 KRAS & TP53 mutations cause malignant mesothelioma Source: ERS Lung Science Conference 2017 Year: 2017 Clinical relevance of p53 and K-ras gene mutations in bronchial margins in surgically treated nonsmall cell lung cancer (NSCLC) patients Source: Eur Respir J 2002; 20: Suppl. 38, 230s Year: 2002 Clinical relevance of p53 and K-ras mutations in nonsmall cell lung cancer (NSCLC) Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001 Association between lung cancer somatic mutations and occupational exposure in never-smokers Source: Eur Respir J, 50 (4) 1700716; 10.1183/13993003.00716-2017 Year: 2017 Other cancers in lung cancer families are overwhelmingly smoking-related cancers Source: ERJ Open Res, 3 (2) 00006-2017; 10.1183/23120541.00006-2017 Year: 2017 Correlation between EGFR mutations and emphysematous changes in heavy smokers with lung cancer Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Mutational status of advanced lung adenocarcinoma in a Portuguese cohort Source: International Congress 2019 – Thoracic oncology: Treatment, diagnostic options and biology Year: 2019 The analysis of CHEK2 gene mutation in small cell lung cancer Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Arg72Pro P53 gene polymorphism is associated with P53 mutations in non-small cell lung cancer (NSCLC) patients Source: Eur Respir J 2004; 24: Suppl. 48, 78s Year: 2004 Small cell lung cancer in never-smokers Source: Eur Respir J 2016; 47: 947-953 Year: 2016 Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations Source: International Congress 2016 – Prognostic variables in lung cancer I Year: 2016 Mutation of TP53 and KRAS, and loss of p16ink4a and p14arf expression in lung cancers in relation to tobacco smoke Source: Eur Respir J 2005; 26: Suppl. 49, 93s Year: 2005 Genes expressions subtraction of non-cancerous tissue from smokers and non-smokers with adenocarcinoma of lung, may be used as markers for early detection of lung cancer in smoker Source: Eur Respir J 2006; 28: Suppl. 50, 812s Year: 2006